Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP·NASDAQ

$450.81

+1.2%
HealthcareMedical - Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

At a Glance

Live Snapshot
Market Cap$12.88B
EPS15.6400
P/E Ratio28.82
Earnings Date07/20/2026

medp

Long Term Debt

Last Annual Value

113.64M

3-Year CAGR

%

5-Year CAGR

%

10-Year CAGR

-11%

Medpace Holdings, Inc.

Medpace Holdings, Inc. Competitors Analysis of Long Term Debt

MEDP · NASDAQ
CompanyLong Term Debt
CAGR 3Y
CAGR 5Y
CAGR 10Y
113.64M
N/AN/A-2.8% 
17.97B
0.5%-0.7%14.5%
TEM logo
Tempus AI, Inc.
NASDAQ:TEM
802.35M
21.3%27.5%N/A
1.41B
-15.2%-1.4%-1.9%
5.70B
9.0%7.3%4.4%
ILMN logo
Illumina, Inc.
NASDAQ:ILMN
1.49B
0.0%-2.5%3.6%
298.40M
60.0%7.4%2.8%
13.09B
-4.2%-3.3%-1.4%
HOLX logo
Hologic, Inc.
NASDAQ:HOLX
2.50B
-0.3%-1.6%-1.9%
Medpace Holdings, Inc.

Medpace Holdings, Inc. Fair Value Envelope

MEDP · NASDAQ

Our analysis suggests that MEDP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $450.815, this represents a potential HIDDEN relative to our calculated worth for Medpace Holdings, Inc..

Intrinsic Value
Current Price: $450.815